Center for Molecular Medicine Cologne

Prof. Dr. med. Rita Schmutzler - Curriculum Vitae

Education and Professional Career

since 2019: Director of the National Center for Familial Tumors (NCFT) at the Center of Integrated Oncology (CIO) of the University Hospital Cologne
since 2012: Director of the Center for Familial Breast and Ovarian Cancer
since 2003: Full professor at the Dept. Ob/Gyn (C3), Div. Molecular Gynaeco-Oncology, University of Cologne
since 1997: Head of the Centre for Familial Breast and Ovarian Cancer at the Universities Cologne and Bonn; supported by German Cancer Aid
1994 - 1997: “Habilitation” fellowship of the DFG at the University of Bonn
1997: Postdoctoral lecturing qualification (Habilitation), University of Bonn
1989 - 1991: Fellowship of the German Research Community (Deutsche Forschungsgemeinschaft, DFG) in Molecular Oncology at Mount Sinai Hospital New York, USA
1989: Practical training course in molecular biology at the EMBL, Heidelberg
1988: Federal Licensing Examination (FLEX), USA
1985 - 1992: Resident in Ob/Gyn, University Womens Hospital of Bonn
1984: Foreign Medical Graduate Examination in the Medical Sciences (FMGEMS), USA
1984 - 1985: Fellowship of the German Academic Exchange Service (DAAD) in Reproductive Medicine at the Eastern Virginia Medical School, Norfolk, VA, USA
1978 - 1984: Medical School and Doctorate, University of Bonn

Awards, distinctions and professional activities

2020: University Award 2020 in the category "Research”
since 2020: Member of the committee of experts of the German Cancer Aid (Deutsche Krebshilfe, DKH)
since 2020: member of the board of TMF, Technology and Methods Platform for Networked Medical Care e.V., umbrella organization for collaborative medical research in Germany, funded by the BMBF
2020: German Cancer Award 2020 (translational part) of the German Cancer Society and the German Cancer Foundation
since 2018: Congress President of PerMediCon (Personalized Medicine Convention, the congress fair for personalized medicine, Cologne)
since 2017: Expert of the S3 guideline commissions for endometrial carcinoma of the German Society for Gynecology and Obstetrics and the German Cancer Society
since 2017: Permanent Guest on the Scientific Advisory Board of the Federal Ministry of Health (BMG)
since 2017: Member and Vice-Chairwoman of the Scientific Advisory Board of the Federal Institute for Drugs and Medical Devices (BfArM)
since 2015: Member of the scientific advisory board of the Institute for Quality and Efficiency in Health Care (IQWIG)
since 2012: Member of the ethics committee of the “National Cohort“ supported by the BMBF
2012 - 2017: Member of the ethics committee of the Biobank of the RWTH Aachen supported by the German Federal Ministry of Education and Research (BMBF)
2011 - 2016: Head of the working group on hereditary tumors (Arbeitsgemeinschaft für erbliche Tumorerkrankungen, AET) of the German Cancer Society (Deutsche Krebsgesellschaft, DKG)
2010 - 2012: Elected board member of the DGGG
2010 - 2012: Member of the ethics committee at the “Bundesärztekammer”
since 2010: Founding member of the patient advocacy group for persons at risk for breast and ovarian cancer (
2010: Gunther-Bastert-Innovation Award of the DGGG
since 2009: Member of the committee on the genetic diagnostic act at the Robert-Koch-Institut
2008 - 2016: Member of the committee of experts (Fachkollegiat) of the DFG
2008 - 2012: Member of the German National Cancer Plan, Speaker of the paper “Risk-adjusted Cancer Screening"
since 2007: Member of the national S3 guideline committee on breast cancer
since 2005: Speaker of the German Consortium for Hereditary Breast- and Ovarian Cancer
2004 - 2012: Member of the committee of experts of the “Deutsche Krebshilfe”, DKH
1998: Ingrid-zu-Solms Award of the „Deutscher Ärztinnenbund“, DÄB
1997: Walter-Hohlweg Award of the DGGG
1991: Research Award: „Niederrheinisch-Westf. Gesellschaft für Gynäkologie und Geburtshilfe“
1989: Research Award: „Deutsche Gesellschaft für Gynäkologie und Geburtshilfe“, DGGG


Link to PubMed